Built on the combined strengths of IPEM, HBI and a strong China-based network spanning government, healthcare institutions, investors, industry leaders and innovation partners, FHIM serves as a trusted bridge between two of the world’s most dynamic healthcare ecosystems.

More than an annual event, FHIM operates through an ongoing framework of membership, strategic dialogue, advisory services, business matchmaking and project development, transforming connections into long-term partnerships and tangible outcomes.

A key part of FHIM is its curated 1-to-1 matchmaking. FHIM has built a comprehensive mapping of China’s biotech landscape and maintains direct insight into the BD priorities and partnership needs of Chinese companies. Based on each company’s development stage, asset profile and transaction objectives, FHIM identifies relevant partners and facilitates targeted meetings between international participants and the appropriate Chinese founders, CEOs and senior decision-makers. This matchmaking begins before the event and is designed to support continued engagement beyond the meeting itself.

learn more about FHIM 2026